Advertisement

PET and Cardiac Infections

  • Deborah Pencharz
Chapter
Part of the Clinicians’ Guides to Radionuclide Hybrid Imaging book series (CGRHI)

Abstract

A range of organisms including viral, bacterial, and fungal can infect the endocardium, cardiac prosthetic devices, pericardium, and myocardium. Currently, most evidence on the use of FDG PET/CT regards its use in prosthetic cardiac components and valves. It should also be noted that echocardiography, CT, and MRI play a useful role in the investigation of potential or proven cardiac infections. A good overview of these modalities, together with helpful descriptions of the pathophysiology of cardiac infections, has been described in a recent review article [1].

References

  1. 1.
    Murillo H, Restrepo CS, Marmol-Velez JA, Vargas D, Ocazionez D, Martinez-Jimenez S, et al. Infectious diseases of the heart: pathophysiology, clinical and imaging overview. Radiographics. 2016;36(4):963–83.CrossRefPubMedGoogle Scholar
  2. 2.
    Harisankar CN, Mittal BR, Agrawal KL, Abrar ML, Bhattacharya A. Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake. J Nucl Cardiol. 2011;18(5):926–36.CrossRefPubMedGoogle Scholar
  3. 3.
    Williams G, Kolodny GM. Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. AJR Am J Roentgenol. 2008;190(2):W151–6.CrossRefPubMedGoogle Scholar
  4. 4.
    Lum DP, Wandell S, Ko J, Coel MN. Reduction of myocardial 2-deoxy-2-[18F]fluoro-D-glucose uptake artifacts in positron emission tomography using dietary carbohydrate restriction. Mol Imaging Biol. 2002;4(3):232–7.CrossRefPubMedGoogle Scholar
  5. 5.
    Scholtens AM, Verberne HJ, Budde RP, Lam MG. Additional heparin preadministration improves cardiac glucose metabolism suppression over low-carbohydrate diet alone in 18F-FDG PET imaging. J Nucl Med. 2016;57(4):568–73.CrossRefPubMedGoogle Scholar
  6. 6.
    Granados U, Fuster D, Pericas JM, Llopis J, Ninot S, Quintana E, et al. Diagnostic accuracy of 18F-FDG PET/CT in infective endocarditis and implantable cardiac electronic device infection: a cross-sectional study. J Nucl Med. 2016;57(11):1726–32.CrossRefPubMedGoogle Scholar
  7. 7.
    Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633–8.CrossRefPubMedGoogle Scholar
  8. 8.
    The 2015 ESC guidelines for the management of infective endocarditis. Eur Heart J. 2015;36(44):3036–7.Google Scholar
  9. 9.
    Yan J, Zhang C, Niu Y, Yuan R, Zeng X, Ge X, et al. The role of 18F-FDG PET/CT in infectious endocarditis: a systematic review and meta-analysis. Int J Clin Pharmacol Ther. 2016;54(5):337–42.CrossRefPubMedGoogle Scholar
  10. 10.
    Kestler M, Munoz P, Rodriguez-Creixems M, Rotger A, Jimenez-Requena F, Mari A, et al. Role of (18)F-FDG PET in patients with infectious endocarditis. J Nucl Med. 2014;55(7):1093–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Saby L, Laas O, Habib G, Cammilleri S, Mancini J, Tessonnier L, et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol. 2013;61(23):2374–82.CrossRefPubMedGoogle Scholar
  12. 12.
    Scarsbrook A, Barrington S. Evidence based indications for the use of PET-CT in the United Kingdom 2016. https://www.rcr.ac.uk/sites/default/files/publication/bfcr163_pet-ct.pdf.
  13. 13.
    Sarrazin JF, Philippon F, Tessier M, Guimond J, Molin F, Champagne J, et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J Am Coll Cardiol. 2012;59(18):1616–25.CrossRefPubMedGoogle Scholar
  14. 14.
    Ahmed FZ, James J, Cunnington C, Motwani M, Fullwood C, Hooper J, et al. Early diagnosis of cardiac implantable electronic device generator pocket infection using (1)(8)F-FDG-PET/CT. Eur Heart J Cardiovasc Imaging. 2015;16(5):521–30.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Graziosi M, Nanni C, Lorenzini M, Diemberger I, Bonfiglioli R, Pasquale F, et al. Role of (1)(8)F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: a prospective study. Eur J Nucl Med Mol Imaging. 2014;41(8):1617–23.CrossRefPubMedGoogle Scholar
  16. 16.
    Adler Y, Charron P, Imazio M, Badano L, Baron-Esquivias G, Bogaert J, et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36(42):2921–64.CrossRefPubMedGoogle Scholar
  17. 17.
    Dong A, Dong H, Wang Y, Cheng C, Zuo C, Lu J. (18)F-FDG PET/CT in differentiating acute tuberculous from idiopathic pericarditis: preliminary study. Clin Nucl Med. 2013;38(4):e160–5.CrossRefPubMedGoogle Scholar
  18. 18.
    Erba PA, Sollini M, Lazzeri E, Mariani G. FDG-PET in cardiac infections. Semin Nucl Med. 2013;43(5):377–95.CrossRefPubMedGoogle Scholar
  19. 19.
    Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636–48, 48a–48d.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Nuclear MedicineBrighton and Sussex University Hospitals NHS Trust, Royal Sussex County HospitalBrightonUK

Personalised recommendations